Please sign in to follow a disease.
A new way to size heart valves: could the 'circle method' reduce TAVI complications?
NCT ID NCT05844969
First seen Jul 30, 2026 · Last updated Aug 04, 2026 · Updated 3 times
Summary
This study looks at whether the 'circle method' — a way to measure the aortic valve — can help doctors choose the right size replacement valve for people with bicuspid aortic valves who are getting a TAVI procedure. Researchers will review past cases to see if patients whose valve size matched the circle method had fewer complications. The goal is to develop better sizing guidelines for this challenging condition.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If validated, the circle method could help doctors select the optimal valve size for TAVI in patients with bicuspid aortic valves, potentially reducing complications.
- What could go wrong
- This is a retrospective analysis of existing data, not a prospective trial. The findings may not apply to all patients or valve types.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
140 people
The number who actually took part.
- Started
-
Jun 2025
- Finished
-
Jun 2026
- Lead sponsor
-
A research network
The lead sponsor is a research network or cooperative group.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Adult patients with bicuspid valve disease who underwent aortic valve replacement.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with bicuspid aortic valves who underwent aortic valve replacement with a balloon expandable valve (SAPIEN 3 / Ultra) * Computed Tomography data available Exclusion Criteria: \- none
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Aortic stenosis with bicuspid valve are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Guy's and St Thomas NHS Foundation Trust
London, SE17EH, United Kingdom
-
Royal Papworth Hospital NHS Foundation Trust
Cambridge, CB20AY, United Kingdom
-
The Essex Cardiothoracic Centre
Basildon, England, SS16 5NL, United Kingdom
-
University Hospitals Sussex NHS Foundation Trust
Worthing, BN112DH, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study tracks how a common heart valve performs in people born with a bicuspid valve
- 11,000 volunteers help unlock genetic secrets of heart valve disease
- Hunt for heart valve genes launches in 700 volunteers
- Scientists hunt for hidden genes behind aortic aneurysms
- Scientists hunt for genetic clues to aortic aneurysm risk
- New hope for heart valve patients: less invasive procedure tested